Care Bare Rx vs Hers: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Care Bare Rx beats Hers overall, scoring 7.4/10 vs 7.3/10. Choose Care Bare Rx for users who prefer oral glp-1 pills and want a simple, no-appo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.

A side-by-side comparison of Care Bare Rx and Hers covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Care Bare Rx

#31 of 48

7.4/10

Simple GLP-1 provider offering oral pill options with a streamlined no-appointment-needed process.

Visit Care Bare Rx

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Feature	Care Bare Rx	Hers
Our Score	7.4/10	7.3/10
Starting Price	$199/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who prefer oral GLP-1 pills and want a simple, no-appointment process	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand
Ranking	#31	#35

Pros & Cons Compared

Care Bare Rx

Pros

+Both oral pill AND injectable GLP-1 options at the same flat $199/mo rate — flexibility to switch formats
+Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) adds accountability
+Same price at every dose with no hidden fees — simple, transparent billing
+Free shipping included on all orders

Cons

−No publicly available company information — founding date, headquarters, and pharmacy partners are undisclosed
−Very limited independent reviews — difficult to verify patient satisfaction or reliability
−No insurance acceptance — cash-pay only with no HSA/FSA eligibility disclosed

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Our Verdict

Care Bare Rx edges out Hers with a score of 7.4/10 vs 7.3/10. Choose Care Bare Rx if you want: users who prefer oral glp-1 pills and want a simple, no-appointment process. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Care Bare Rx nor Hers feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review